NCT02809261View on ClinicalTrials.gov

The Effect of Perineural Injection Therapy in Patients With Carpal Tunnel Syndrome

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

March 30, 2017

Study Completion Date

March 30, 2017

Conditions
Carpal Tunnel Syndrome
Interventions
PROCEDURE

Ultrasound-guided perineural injection with 5% dextrose

Ultrasound-guided perineural injection with 5% dextrose (3cc) between proximal carpal tunnel and surrounding median nerve with hydrodissection.

PROCEDURE

Ultrasound-guided perineural injection with normal saline

Ultrasound-guided perineural injection with normal saline (3cc) between proximal carpal tunnel and surrounding median nerve with hydrodissection.

DRUG

Normal Saline

Normal saline is safe for perineural injection.

DRUG

5% Dextrose

5% Dextrose could decrease the release of CGRP and substance P to reduce the nerve inflamation.

Trial Locations (1)

886

Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital, Taipei

All Listed Sponsors
lead

Tri-Service General Hospital

OTHER

NCT02809261 - The Effect of Perineural Injection Therapy in Patients With Carpal Tunnel Syndrome | Biotech Hunter | Biotech Hunter